Top Chicago, IL Sales Companies With Best Stability & Growth (95)

Investor Backing & Capital Strength: New growth capital was secured via a $65M growth investment led by existing investors, signaling continued access to funding to support scaling. The investment is repeatedly tied to accelerating adoption and expansion plans into 2026.

Strong Revenue Growth: A milestone of $100M in Contracted ARR (CARR) by the end of 2025 is cited as evidence of expanding contracted recurring revenue. The data is positioned as a major step-up in commercial scale for the artera.io business.

Market Expansion: Customer footprint and usage claims indicate expansion from earlier scale figures to “1,000+ healthcare organizations,” with materially higher annual communication volumes and patients reached. New logo mentions such as adding FQHCs and ongoing segment wins are presented as continued go-to-market traction.

Investor Backing & Capital Strength: A definitive agreement for Advent International to acquire PatientPoint is framed as providing capital and an explicit mandate to accelerate network expansion and product innovation, signaling strong sponsor conviction.

Strong Market Position & Advantage: PatientPoint is repeatedly positioned as operating the nation’s largest digital point-of-care network, with large reported scale in physician-office locations, devices, and provider relationships that supports category leadership.

Market Expansion: Growth signals include the 2021 combination with Outcome Health and ongoing network/footprint expansion claims across tens of thousands of locations, alongside continued deal and partnership activity aimed at extending reach.

Strong Revenue Growth: Revenue run-rate milestones are cited as rising from over $200M annualized by end-2024 to crossing $300M annualized by November 2025, alongside strong booking-volume scaling. These figures are presented as evidence of sustained growth momentum into 2026.

Investor Backing & Capital Strength: A $200M Series E at a $2.7B valuation and an additional credit facility of up to $135M are described as expanding available capital to fund growth. Proceeds are explicitly tied to U.S. expansion and continued AI/product investment.

Product Line Growth: Acquisitions and the subsequent rebrand are described as broadening the platform from travel into unified travel-and-spend, including expenses, invoices, and payments. The AI-native positioning is presented as extending the addressable market beyond travel-only workflows.

Strong Revenue Growth: The company reports an extended streak of year-over-year growth through late 2025, suggesting sustained commercial momentum rather than a single-quarter bump. Brand additions and increased engagement with curated deals are presented as contributing factors to that run-rate.

Innovation-Driven Growth: New product launches such as OpenXSelect and the OpenXBuild API suite indicate ongoing investment in capabilities that are typically used to expand advertiser control and drive adoption. Expansion in CTV offerings and reported increases in CTV spend reinforce a growth narrative tied to product and channel bets.

Strong Hiring & Retention: Headcount estimates and stated plans to expand commercial teams point to active resourcing in support of continued growth initiatives. Leadership appointments and promotions are framed as steps to scale operations and maintain execution pace.

Market Expansion: The company has continued expanding its North American footprint through new offices in markets such as Minneapolis–St. Paul, Toronto, and Guadalajara, supporting cross-border growth. Public updates also reference expanded office space commitments in key hubs like Chicago, signaling sustained capacity build-out.

Strong Hiring & Retention: Hiring plans point to continued organizational scaling, including intentions to add hundreds of roles across North America in 2025. Team growth in 2024 and a stated hiring pipeline for 2025 further indicate continued investment in staffing to support volumes.

Profitability: Management highlights sustained EBITDA positivity while continuing to invest in technology and productivity initiatives. This positioning suggests growth efforts are being pursued with an emphasis on maintaining profitability rather than expanding at any cost.

Investor Backing & Capital Strength: A large strategic growth investment is described as providing capital to accelerate product development, sales/support, and recruiting. This level of backing signals capacity to fund multi-year scaling initiatives.

Product Line Growth: Multiple acquisitions and subsequent module launches expanded the platform from core PSA into areas like resource planning, quoting/CPQ, and broader services lifecycle coverage. This indicates widening product scope intended to support cross-sell and upmarket capability.

Strategic Partnerships: A new integration with Intuit Enterprise Suite is presented as extending ecosystem reach and improving platform stickiness for target customers. This kind of integration can strengthen distribution and reduce switching friction.

Innovation-Driven Growth: Product releases continued through 2025 alongside implemented AI workflows and the launch of “Ask ALIS,” indicating sustained investment in new capabilities. The “ALIS 500” benchmarking program also expands the product surface into operational and clinical analytics using large-scale community data.

Strategic Partnerships: Client and vendor partnerships expanded in 2025, and the company highlighted deeper ecosystem activity through integrations and partner announcements. Processing large payment volumes and reporting growth in vendor partnerships suggest increasing embeddedness in operators’ workflows and adjacent vendor stacks.

Strong Hiring & Retention: Team growth was reported alongside broader scaling activities such as hosting the first user conference and expanding partnerships. External directories and LinkedIn headcount bands also align with an organization adding capacity to support expansion, even if exact figures are not company-verified.

Investor Backing & Capital Strength: Fresh funding is highlighted through a completed Series B on September 22, 2025, bringing total funding to “nearly $50 million,” and described as oversubscribed by existing investors. This level of capital is framed as supporting headcount, product, and go-to-market expansion.

Strong Hiring & Retention: Active hiring is indicated by open roles on a Greenhouse board (e.g., Marketing Director; Sales Development Representative with a March/April start), suggesting continued team buildout. Team scale signals also appear via a LinkedIn range of 51–200 employees and frequent posts about new hires and open roles.

Product Line Growth: Ongoing product and market activity is implied by frequent, recent blog posts (including February 2026) and new case studies through late 2025. This cadence is presented as reflecting active marketing and customer engagement alongside continued feature releases.